A possible explanation for keeping CDH17 levels in tumor emboli, even when tumor staging is T3, may be related to the early stages of their formation—detachment of tumor cells is possible through the loss of other adhesion molecules, while CDH17 remains stable. Here, CDH17 is linked to neoplasm.